Literature DB >> 10357048

High-dose fluconazole therapy in patients with severe fungal infections.

A Voss1, B E de Pauw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10357048     DOI： 10.1007/s100960050252

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

Review 1.  Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.

Authors:  M A Pfaller; D J Diekema; D J Sheehan
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.

Authors:  Kelly C Wade; Daniel K Benjamin; David A Kaufman; Robert M Ward; Phillip B Smith; Bhuvana Jayaraman; Peter C Adamson; Marc R Gastonguay; Jeffrey S Barrett
Journal:  Pediatr Infect Dis J       Date:  2009-08       Impact factor: 2.129

Review 3.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  [Invasive mycoses and trauma].

Authors:  Alexandra Obradovic; Stefan Hajdu; Elisabeth Presterl
Journal:  Wien Med Wochenschr       Date:  2007

Review 5.  The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.

Authors:  John E Bennett
Journal:  J Antimicrob Chemother       Date:  2009-05       Impact factor: 5.790

6.  Isolation of fluconazole-tolerant micromycetes onto different cultivation media.

Authors:  Z Kunová; E Piecková
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

Review 7.  Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.

Authors:  H Ruth Ashbee; Rosemary A Barnes; Elizabeth M Johnson; Malcolm D Richardson; Rebecca Gorton; William W Hope
Journal:  J Antimicrob Chemother       Date:  2013-12-29       Impact factor: 5.790

8.  Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.

Authors:  Mahipal G Sinnollareddy; Jason A Roberts; Jeffrey Lipman; Murat Akova; Matteo Bassetti; Jan J De Waele; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; George Dimopoulos
Journal:  Crit Care       Date:  2015-02-04       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.